{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:54:59Z","timestamp":1794048899648,"version":"4.8.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007131","name":"Texas Tech University","doi-asserted-by":"publisher","award":["5.822"],"award-info":[{"award-number":["5.822"]}],"id":[{"id":"10.13039\/100007131","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jhep.2022.05.023","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T21:14:54Z","timestamp":1653686094000},"page":"957-966","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["Hepatitis D virus-induced interferon response and administered interferons control cell division-mediated virus spread"],"prefix":"10.1016","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0013-3685","authenticated-orcid":false,"given":"Zhenfeng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1197-4161","authenticated-orcid":false,"given":"Yi","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6103-8078","authenticated-orcid":false,"given":"Florian A.","family":"Lempp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0430-2095","authenticated-orcid":false,"given":"Pascal","family":"Mutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5601-9307","authenticated-orcid":false,"given":"Ralf","family":"Bartenschlager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1560-8038","authenticated-orcid":false,"given":"Stephan","family":"Urban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2022.05.023_bib1","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1055\/s-0032-1323628","article-title":"Clinical features of hepatitis D","volume":"32","author":"Farci","year":"2012","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2022.05.023_bib2","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jhep.2010.06.008","article-title":"Outcome of chronic delta hepatitis in Italy: a long-term cohort study","volume":"53","author":"Niro","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.05.023_bib3","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jhep.2021.01.014","article-title":"The changing context of hepatitis D","volume":"74","author":"Rizzetto","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.05.023_bib4","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jhep.2020.04.008","article-title":"The global prevalence of hepatitis D virus infection: systematic review and meta-analysis","volume":"73","author":"Stockdale","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.05.023_bib5","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1093\/infdis\/jiz633","article-title":"Estimating the global prevalence, disease progression, and clinical outcome of hepatitis delta virus infection","volume":"221","author":"Miao","year":"2020","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jhep.2022.05.023_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104812","article-title":"Current knowledge on hepatitis delta virus replication","volume":"179","author":"Lucifora","year":"2020","journal-title":"Antivir Res"},{"key":"10.1016\/j.jhep.2022.05.023_bib7","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1038\/s41467-019-10117-z","article-title":"Enveloped viruses distinct from HBV induce dissemination of hepatitis D virus in\u00a0vivo","volume":"10","author":"Perez-Vargas","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2022.05.023_bib8","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/gutjnl-2017-314713","article-title":"Hepatitis delta virus persists during liver regeneration and is amplified through cell division both in\u00a0vitro and in\u00a0vivo","volume":"68","author":"Giersch","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2022.05.023_bib9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/hep.1840210211","article-title":"Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis","volume":"21","author":"Samuel","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.05.023_bib10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jhep.2011.06.016","article-title":"Rapid early HDV RNA decline in the peripheral blood but prolonged intrahepatic hepatitis delta antigen persistence after liver transplantation","volume":"56","author":"Mederacke","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.05.023_bib11","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jhep.2013.11.010","article-title":"Persistent hepatitis D virus mono-infection in humanized mice is efficiently converted by hepatitis B virus to a productive co-infection","volume":"60","author":"Giersch","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.05.023_bib12","article-title":"A\u00a0phase 2 study of lonafarnib, ritonavir and peginterferon lambda for 24 weeks: interim end-of-treatment results from the LIFT HDV study","author":"Koh","year":"2019","journal-title":"AASLD"},{"key":"10.1016\/j.jhep.2022.05.023_bib13","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/S0618-8278(19)30141-0","article-title":"Final results of a multicenter, open-label phase 2 clinical trial (MYR203) to assess safety and efficacy of myrcludex B in cwith PEG-interferon Alpha 2a in patients with chronic HBV\/HDV co-infection","volume":"70","author":"Wedemeyer","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.05.023_bib14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/hep.27102","article-title":"Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta","volume":"60","author":"Heidrich","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.05.023_bib15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1473-3099(18)30663-7","article-title":"Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial","volume":"19","author":"Wedemeyer","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jhep.2022.05.023_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104995","article-title":"Effectiveness of pegylated interferon monotherapy in the treatment of chronic hepatitis D virus infection: a meta-analysis","volume":"185","author":"Abdrakhman","year":"2021","journal-title":"Antivir Res"},{"key":"10.1016\/j.jhep.2022.05.023_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jhep.2018.02.021","article-title":"Hepatitis D virus replication is sensed by MDA5 and induces IFN-beta\/lambda responses in hepatocytes","volume":"69","author":"Zhang","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.05.023_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2021.03.025","article-title":"Assembly and infection efficacy of hepatitis B virus surface protein exchanges in 8 hepatitis D virus genotype isolates","author":"Wang","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.05.023_bib19","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1038\/s41467-019-10211-2","article-title":"Recapitulation of HDV infection in a fully permissive hepatoma cell line allows efficient drug evaluation","volume":"10","author":"Lempp","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2022.05.023_bib20","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.1128\/JVI.77.9.5519-5523.2003","article-title":"Role of N glycosylation of hepatitis B virus envelope proteins in morphogenesis and infectivity of hepatitis delta virus","volume":"77","author":"Sureau","year":"2003","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jhep.2022.05.023_bib21","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jhep.2015.10.030","article-title":"Evidence that hepatitis B virus replication in mouse cells is limited by the lack of a host cell dependency factor","volume":"64","author":"Lempp","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.05.023_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/v13071207","article-title":"HDV-like viruses","volume":"13","author":"Perez-Vargas","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.jhep.2022.05.023_bib23","doi-asserted-by":"crossref","first-page":"e00014","DOI":"10.1128\/mBio.00014-19","article-title":"Identification of a novel deltavirus in Boa constrictors","volume":"10","author":"Hetzel","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.jhep.2022.05.023_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.03250-19","article-title":"Snake deltavirus utilizes envelope proteins of different viruses to generate infectious particles","volume":"11","author":"Szirovicza","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.jhep.2022.05.023_bib25","doi-asserted-by":"crossref","first-page":"17977","DOI":"10.1073\/pnas.2006750117","article-title":"Mammalian deltavirus without hepadnavirus coinfection in the neotropical rodent Proechimys semispinosus","volume":"117","author":"Paraskevopoulou","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2022.05.023_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022415","article-title":"Interferon impedes an early step of hepatitis delta virus infection","volume":"6","author":"Han","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2022.05.023_bib27","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1038\/s41598-017-03946-9","article-title":"Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV\/HDV infected humanized mice","volume":"7","author":"Giersch","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2022.05.023_bib28","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jhep.2017.05.010","article-title":"A\u00a0new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-beta induction","volume":"67","author":"Suarez-Amaran","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.05.023_bib29","first-page":"3","article-title":"A\u00a0review on hepatitis D: from virology to new therapies","volume":"17","author":"Mentha","year":"2019","journal-title":"J\u00a0Adv Res"},{"key":"10.1016\/j.jhep.2022.05.023_bib30","first-page":"967","article-title":"Standard and pegylated interferon therapy of HDV infection: a systematic review and meta- analysis","volume":"17","author":"Alavian","year":"2012","journal-title":"J\u00a0Res Med Sci"},{"key":"10.1016\/j.jhep.2022.05.023_bib31","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01885-18","article-title":"Cell cycle arrest in G2\/M phase enhances replication of interferon-sensitive cytoplasmic RNA viruses via inhibition of antiviral gene expression","volume":"93","author":"Bressy","year":"2019","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jhep.2022.05.023_bib32","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/jvh.12947","article-title":"Viral dominance patterns in chronic hepatitis delta determine early response to interferon alpha therapy","volume":"25","author":"Lutterkort","year":"2018","journal-title":"J\u00a0Viral Hepat"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827822003385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827822003385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:47:09Z","timestamp":1759175229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827822003385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0168827822003385"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2022.05.023","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis D virus-induced interferon response and administered interferons control cell division-mediated virus spread","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2022.05.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}